Welcome to our dedicated page for KLUDEIN I ACQUISITION news (Ticker: INKAU), a resource for investors and traders seeking the latest updates and insights on KLUDEIN I ACQUISITION stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect KLUDEIN I ACQUISITION's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of KLUDEIN I ACQUISITION's position in the market.
KludeIn I Acquisition Corp. (NASDAQ: INKAU) announced that effective March 1, 2021, holders of units from its initial public offering can separately trade shares of Class A common stock and warrants. Class A Common Stock will trade under the symbol 'INKA', and warrants under 'INKAW'. Units that remain unseparated will continue to trade under 'INKAU'. The registration statement for these securities was effective as of January 6, 2021. The company is a blank check firm seeking mergers or acquisitions, focusing on high-quality software or tech-enabled growth businesses.
KludeIn I Acquisition Corp. announced the pricing of its initial public offering (IPO) of 15 million units at $10.00 per unit, set to trade under the ticker symbol INKAU on Nasdaq starting January 7, 2021. Each unit includes one share of Class A common stock and half a redeemable warrant, allowing for the purchase of additional shares at $11.50 each. The IPO is expected to close on January 11, 2021, with a 45-day option for underwriters to purchase up to 2.25 million additional units. The Company aims to engage in business combinations in various sectors.
